Search results
Oct 23, 2019 · Exclusive Show. Patients in search of a miracle cure end up in critical condition. The race is on to find out what went wrong before more people get hurt. The trail leads back to a medical company with slick marketing and a charismatic CEO. And to a multibillion dollar stem cell industry where greed and desperation collide.
- The Entrepreneur
For accurate information on stem cell treatments, visit the...
- Introducing Bad Batch
Patients in search of a miracle cure end up in critical...
- Beyond Liveyon
Shows > Bad Batch > Beyond Liveyon. Nov 14, 2019 • 40 min....
- The Sell
John K. builds his company, and focuses on what he does...
- The Entrepreneur
Nov 14, 2019 · Bad Batch Tells a Story of Stem Cells Gone Wrong. November 14, 2019. by Jake Greenberg. (Credit: Wondery) Bad Batch is the latest in Wondery’s “something medical goes very, very wrong” series. Like its predecessors, Bad Batch is highly-competent, anchored by host Laura Beil, who brings the same reporting vigor she did to last year’s Dr ...
12 episodes. Patients in search of a miracle cure end up in critical condition. The race is on to find out what went wrong before more people get hurt. The trail leads back to a medical company with slick marketing and a charismatic CEO. And to a multibillion dollar stem cell industry where greed and desperation collide.
- (8.6K)
- Wondery
Oct 30, 2019 · Bad Batch podcast is must listen for stem cell community. By Professor Paul Knoepfler, Ph.D. / 10 Comments / October 30, 2019 / Alan Gaveck, Bad Batch, Genetech, John Kosolcharoen, Liveyon / Patients, Reviews. Bad Batch Podcast, click here to listen.
Bad Batch is a podcast that digs deep into the archives of an industry to understand why we seek unproven miracle cures and how dangerous that may be. Under the scrutiny of reporter Laura Beil, the stem cell industry appears to be defined as much by avarice and recklessness as by its incredible scientific benefits.
Nov 5, 2019 · The stories in the podcast range from rural Wisconsin residents successfully healed by stem cells to a biomedical consultant in Thailand who left a stem cell research company after he...
The race is on to find out what went wrong before more people get hurt. The trail leads back to a medical company with slick marketing and a charismatic CEO. And to a multibillion dollar stem cell industry where greed and desperation collide.
